Ads
related to: renal
Search results
Drugs like Ozempic could protect kidney health in people with heart disease, obesity
MedicalNewsToday via AOL· 7 days agoData from a new clinical trial suggest that people with obesity and cardiovascular disease who use...
Novartis (NVS) Presents Positive Data on Renal Drugs at ERA
Zacks via Yahoo Finance· 5 days agoThe study also showed that Fabhalta has a favorable safety profile with no new safety signal. The...
Calcium and CV Risk: Are Supplements and Vitamin D to Blame?
Medscape· 2 days agoTricia Ward and Matthew Budoff discuss the impact of dietary intake of calcium and calcium...
Multiphase comparative study for WHO/ISUP nuclear grading diagnostic model based on enhanced CT...
Nature· 5 days agoTo compare and analyze the diagnostic value of different enhancement stages in distinguishing low and high nuclear grade clear cell renal cell carcinoma (ccRCC) based on enhanced ...
Ozempic and Wegovy could double as kidney disease treatment, study suggests
Fox News· 1 day agoSemaglutide medications — including Ozempic and Wegovy — have been shown to reduce the risk of...
Novartis presents latest Phase III Fabhalta® (iptacopan) data in C3 glomerulopathy (C3G) showing...
WROC Rochester· 7 days agoNovartis today presented results from the 6-month, double-blind period of the Phase III APPEAR-C3G...
Interim results of IGNAZ trial sheds positive light on felzartamab for IgAN
Clinical Trials Arena via Yahoo Finance· 3 days agoAt this year’s European Renal Association Congress, positive interim results were presented from...
Independent Dialysis Group Opening New Facility in Wellsboro, Pennsylvania
WENY-TV· 2 days agoProviding care in communities like Wellsboro is a challenge many healthcare providers face as...
May 31 2024 This Week in Cardiology
Medscape· 24 hours agoFor more insight and commentary on these stories, subscribe to the This Week in Cardiology podcast, download the Medscape app or subscribe on Apple...
HI-Bio Announces Positive Results from Phase 2 Study of Felzartamab for Late Antibody-Mediated...
FOX21 Colorado Springs· 7 days ago...versus 20% (n=2/10) who received placebo, and patients treated with felzartamab showed reductions in disease-linked biomarkers and stabilization of eGFR 63% (n=7/11) of felzartamab-treated patients achieved microvascular inflammation (MVI) score of 0 and 100% (n=11/11) of felzartamab treated...